-
Nov 2007
NeuClone receives COMET grant funding
-
COMET (Commercialising Emerging Technologies) is an Australian government initiative offered through AusIndustry COMET is a competitive, merit based program that supports early-growth stage and spin off companies to successfully commercialize their innovations.
-
July 2007
NeuClone signs deal to develop CHO cell lines for the Latin American market
-
NeuClone has entered into a supply agreement with a leading pharmaceutical company in Mexico to provide fully documented mammalian cell lines producing biosimilars for distribution in the Latin American market.